Skip to main content
Fig. 4 | Journal of Translational Medicine

Fig. 4

From: CYT387, a potent IKBKE inhibitor, suppresses human glioblastoma progression by activating the Hippo pathway

Fig. 4

CYT387 arrests glioblastoma cell cycle on G2/M phase. A, B CYT387 arrested U87-MG and LN229 cell cycle on G2/M phase. C Cell cycle markers cyclinA2, cyclinD1, cyclinB1, cdk1 and Cdc25c were detected by western blot after treatment with CYT387. All experiments were repeated at least three times. (*p < 0.05; **p < 0.01; ***p < 0.001)

Back to article page